FDA.reportPublic FDA data

0.7 ML Enflonsia 150 MG/ML Prefilled Syringe

RxCUI
2716816
RxNorm name
0.7 ML Enflonsia 150 MG/ML Prefilled Syringe
Display name
0.7 ML Enflonsia 150 MG/ML Prefilled Syringe
Full name
0.7 ML Enflonsia 150 MG/ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761432Enflonsiaclesrovimab-cfor351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c9004a92-40e8-4cdb-b22d-d07929f8fc3bENFLONSIA 105 MG in 0.7 ML Prefilled Syringe [PSN] · 0.7 ML clesrovimab-cfor 150 MG/ML Prefilled Syringe [Enflonsia] [SBD] · 0.7 ML Enflonsia 150 MG/ML Prefilled Syringe [SY] · Enflonsia 105 MG per 0.7 ML Prefilled Syringe [SY]43These highlights do not include all the information needed to use ENFLONSIA safely and effectively. See full prescribing information for ENFLONSIA. ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use Initial U.S. Approval: 202520250620